Discovery - University of Dundee - Online Publications

Library & Learning Centre

Methylation of the calcium channel regulatory subunit alpha 2 delta-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas

Methylation of the calcium channel regulatory subunit alpha 2 delta-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas

Research output: Contribution to journalArticle

View graph of relations

Authors

  • C. Palmieri
  • B. Rudraraju
  • M. Monteverde
  • L. Lattanzio
  • O. Gojis
  • R. Brizio
  • O. Garrone
  • M. Merlano
  • N. Syed
  • C. Lo Nigro
  • T. Crook

Research units

Info

Original languageEnglish
Pages375-381
Number of pages7
JournalBritish Journal of Cancer
Journal publication date10 Jul 2012
Journal number2
Volume107
DOIs
StatePublished

Abstract

BACKGROUND: Calcium is an important intracellular messenger that mediates many biological processes that are relevant to the malignant process. Calcium ion channels are key in controlling the intracellular calcium, and little is known about their role in human cancer.

METHODS: We used qPCR and pyrosequencing to investigate expression and epigenetic regulation of the calcium channel regulatory subunit alpha 2 delta-3 (CACNA2D3) in breast cancer cell lines, primary cancers and metastatic lesions.

RESULTS: Expression of CACNA2D3 mRNA is regulated in breast cancer cell lines by methylation in the CpG island located in the 50 regulatory region of the gene. Expression is upregulated by azacytidine (AZA) in cells with CpG island methylation but unaffected in cells lacking methylation. In primary breast carcinomas, methylation is more common in cancers, which subsequently relapse with loco-regional and, particularly, visceral metastatic disease in both oestrogen receptor-alpha (ER)-positive and -negative cases. Furthermore, CACNA2D3 CpG island is frequently methylated in breast cancer that has metastasised to the central nervous system.

CONCLUSION: Methylation-dependent transcriptional silencing of CACNA2D3 may contribute to the metastatic phenotype of breast cancer. Analysis of methylation in the CACNA2D3 CpG island may have potential as a biomarker for risk of development of metastatic disease. British Journal of Cancer (2012) 107, 375-381. doi:10.1038/bjc.2012.231 www.bjcancer.com Published online 29 May 2012 (c) 2012 Cancer Research UK

Documents

Library & Learning Centre

Contact | Accessibility | Policy